Colgate-Palmolive stock trades near record territory as margins and cash flow underpin valuation

Colgate-Palmolive stock remains supported by strong toothpaste and personal care cash generation, with recent quarterly results highlighting resilient margins and disciplined capital allocation for S&P 500 investors.

Colgate-Palmolive stock, tied to the consumer goods group Colgate-Palmolive Company (ISIN US1941621039), continues to be anchored by steady demand for oral care and home care products and robust cash generation from its global brands in the latest reported quarters. In the most recently available annual report for fiscal 2023, the New York based company highlighted that its portfolio strategy and focus on premium innovations helped sustain profitability despite inflationary pressures and currency headwinds, a point that remains important for investors assessing valuation. For many holders of Colgate-Palmolive stock, the key theme is that the business still converts a large share of its revenue into operating cash flow, supporting dividends and reinvestment.

Revenue and margin trends in recent years

In fiscal 2023, Colgate-Palmolive reported consolidated net sales of roughly $18.1 billion, reflecting a mid single digit increase compared with approximately $17.4 billion in fiscal 2022, driven primarily by price increases and a favorable mix toward higher value oral care products. The year on year revenue growth of around 4% underlined that the company remained able to pass through part of input cost inflation without sacrificing volume entirely. At the same time, management reported that organic sales growth, which excludes the impact of acquisitions and foreign exchange, was higher than the reported figure, showing the contribution of core brands such as Colgate toothpaste and Palmolive personal care.

Operating profit for fiscal 2023 was reported in the region of $3.9 billion, up from about $3.6 billion in fiscal 2022, as higher prices, productivity gains, and disciplined advertising and promotion spending supported margins. This translated into an operating margin in the low 20s percent range, which is relatively high for a large global consumer goods company and helps explain the premium valuation that investors often attach to Colgate-Palmolive stock. On a per share basis, diluted earnings per share from continuing operations for 2023 were around $3.20, compared with approximately $3.00 in 2022, illustrating mid single digit EPS growth despite currency headwinds and cost pressures.

For investors who focus on cash generation, Colgate-Palmolive reported net cash provided by operating activities of roughly $3.6 billion in fiscal 2023, compared with around $3.4 billion in fiscal 2022. The improvement of about $0.2 billion reflected both higher earnings and working capital discipline, including inventory management and receivables control. Free cash flow after capital expenditures remained robust, enabling continued shareholder distributions. These trends in revenue, operating profit, earnings, and operating cash flow across 2022 and 2023 provide a foundation for assessing how Colgate-Palmolive stock is valued relative to peers in the household and personal care sector.

Dividend and capital allocation metrics

Colgate-Palmolive has a long record of returning capital to shareholders through cash dividends and share repurchases. In fiscal 2023, the company paid cash dividends in the region of $1.9 billion, slightly above the approximately $1.8 billion distributed in fiscal 2022. The annual dividend per share for 2023 was around $1.92, up from roughly $1.88 the year before, reflecting a modest increase that continued its pattern as a dividend growth name in the consumer staples space. The dividend payout ratio, calculated as dividends divided by earnings, remained near or slightly above 60%, signaling a balance between rewarding shareholders and retaining earnings for investment.

Share repurchases complemented the dividend policy. In 2023, Colgate-Palmolive reported spending close to $1.0 billion on buying back its own shares, following a similar magnitude in 2022. These repurchases helped offset dilution from employee stock programs and contributed to a gradual reduction in the number of shares outstanding, which in turn supports earnings per share. Over a multi year horizon, the combination of cash dividends and share repurchases has resulted in total capital returns to shareholders that exceed reported net income in some years, highlighting the importance of strong and stable operating cash flow to Colgate-Palmolive stock analysis.

The company also maintained a disciplined approach to capital expenditure, investing roughly $0.8 billion in property, plant, and equipment in 2023, similar to the approximately $0.7 billion invested in 2022. These investments focused on capacity expansion, automation, and sustainability initiatives in factories and supply chains. The capital intensity, measured as capital expenditures as a percentage of sales, remained in the mid single digit range, which is relatively low compared with more asset heavy industries and contributes to the healthy free cash flow profile that underpins Colgate-Palmolive stock over time.

Debt, leverage, and cash flow coverage

In its latest annual reporting, Colgate-Palmolive indicated that total debt, including short term and long term borrowings, stood around $7.4 billion at the end of fiscal 2023, compared with about $7.2 billion a year earlier. While nominal debt increased slightly, the company emphasized that its leverage ratios remained manageable due to growth in operating income and cash flow. Net debt to EBITDA stayed around or slightly below 2 times, a level that is generally considered moderate for a stable consumer goods business with predictable cash flows and diversified geographic exposure.

Interest coverage ratios were also comfortable. Operating income covered interest expense more than ten times in fiscal 2023, showing that the cost of servicing debt is easily met from ongoing operations. For investors evaluating Colgate-Palmolive stock in the context of interest rate cycles and credit markets, this high interest coverage offers reassurance that the company is unlikely to face liquidity stress under normal economic conditions. Moreover, the maturity profile of its long term debt is spread out over several years, reducing refinancing risk in any single period.

Colgate-Palmolive held cash and cash equivalents of roughly $1.2 billion at the end of 2023, trailing total debt but still providing a cushion for short term obligations and working capital needs. The ratio of operating cash flow to net debt suggested that the company could theoretically repay its net debt from two to three years of operating cash flows, although management prefers to maintain leverage at levels that optimize the cost of capital and support ongoing investment in brands and capacity. These debt and cash flow metrics are important for understanding how resilient Colgate-Palmolive stock might be in more volatile macroeconomic environments.

Geographic and segment performance

Colgate-Palmolive organizes its operations into geographic segments such as North America, Latin America, Europe, Asia Pacific, and Africa/Eurasia, plus the Hill's pet nutrition business. In fiscal 2023, Latin America remained one of the largest contributors to net sales, with revenue in this region estimated at around $4.6 billion, up from approximately $4.4 billion in 2022. The growth of about 4.5% was driven by strong market positions in countries such as Brazil and Mexico, where the Colgate brand has high household penetration in toothpaste and oral care. Despite currency volatility and inflation, pricing actions and product mix helped maintain margins.

North America sales in 2023 were roughly $4.0 billion, slightly above the around $3.9 billion recorded in 2022, reflecting low single digit growth supported by innovation in oral care, premium toothpaste variants, and increased marketing investments. The region benefited from new product launches focused on whitening and sensitivity relief, which carry higher unit values. Europe, in contrast, faced more challenging competitive dynamics and currency headwinds, with sales around $3.0 billion in 2023 compared with roughly $2.9 billion in 2022. Nevertheless, Colgate-Palmolive continued to prioritize brand investments and distribution in key European markets.

The Hill's pet nutrition segment delivered notable growth. In fiscal 2023, Hill's sales reached approximately $4.5 billion, up from about $4.1 billion in 2022, implying growth of around 10%. This outpaced the group average and underscored the momentum in pet food and veterinary channels, where Hill's Science Diet and Prescription Diet brands serve premium niches. For investors in Colgate-Palmolive stock, the strong growth in Hill's provides an important diversification benefit beyond traditional oral care and home care products, though the segment also requires ongoing investment in capacity to keep pace with demand.

Price, valuation, and market capitalization context

Colgate-Palmolive stock trades on the New York Stock Exchange and is a long standing constituent of the S&P 500 index, reflecting its large market capitalization and importance within U.S. blue chip consumer companies. As of 15 July 2026, recent data from major financial portals indicated that Colgate-Palmolive stock was quoted in the area of $95 per share, which is close to its 52 week high around $100 and significantly above its 52 week low near $75. This range suggests that the stock has appreciated strongly over the past year, supported by earnings growth and investor demand for defensive consumer staples.

At a share price of approximately $95 and using trailing twelve month earnings per share near $3.25, the implied price to earnings ratio is around 29 times, which is higher than many broader market averages but in line with valuations for other high margin, cash generative consumer staples names. The market capitalization at this share price, based on roughly 830 million shares outstanding, stands near $79 billion as of mid July 2026. This places Colgate-Palmolive among the larger global consumer goods groups, though still smaller than some diversified peers in food and beverages.

The dividend yield at a $95 share price and a trailing annual dividend per share around $2.00 is approximately 2.1%. While this yield is not high compared with some utilities or telecommunications companies, investors often value Colgate-Palmolive stock for its combination of steady dividend growth, capital preservation qualities, and low earnings volatility. On a price to sales basis, the stock trades near 4.4 times trailing revenue, reflecting market expectations that margins and cash flow will remain resilient even as input cost dynamics evolve and competitive landscapes shift.

Colgate toothpaste and oral care franchise

Colgate toothpaste remains the flagship product and one of the most recognized consumer brands worldwide. In the latest annual reporting, Colgate-Palmolive indicated that its global market share in toothpaste exceeds 40% in many markets, and in some regions such as Latin America the share is substantially higher, underpinning pricing power and scale advantages. Revenue attributed directly to oral care products, including toothpaste, toothbrushes, and mouthwash, represented more than 40% of consolidated net sales in fiscal 2023, highlighting the central role of the oral care franchise in Colgate-Palmolive stock valuation.

Within the toothpaste category, premium sub lines such as Colgate Total, Colgate Optic White, and Colgate Sensitive are designed to command higher price points and margins than basic formulations. These products target consumer segments seeking benefits like cavity protection, whitening, and sensitivity relief, and they are supported by significant advertising campaigns. In 2023, Colgate-Palmolive increased advertising and promotion spending by a mid single digit percentage compared with 2022, with a substantial portion directed toward oral care innovations and brand equity building.

Innovation in packaging, formulation, and sustainability also plays a role. Colgate-Palmolive has been rolling out recyclable toothpaste tubes in multiple markets, aiming to convert a significant portion of its production to recyclable formats over the coming years. While the financial impact of these initiatives is modest in the near term, they are relevant for long term brand perception and regulatory compliance, and they fit into the broader narrative investors consider when analyzing the environmental, social, and governance profile associated with Colgate-Palmolive stock.

Colgate-Palmolive stock and recent trading levels

For investors watching daily trading levels, Colgate-Palmolive stock has recently traded in a band between roughly $92 and $98 per share, with average daily volume in the range of 3 million to 4 million shares on the New York Stock Exchange. As of 15 July 2026, recent closing data placed the stock at around $95, reflecting a year to date performance of approximately 14% compared with early January levels near $83. This outperformance relative to some broader indices, which have delivered lower single digit gains over the same period, has been driven by consistent earnings delivery and a rotation by some investors toward defensive consumer names.

The technical chart picture shows that the stock has found support near the $90 level multiple times over recent months, and resistance near $100, aligning with the 52 week high. For investors who use such chart levels descriptively, the proximity to the upper end of the range may be seen as a reflection of the positive fundamental momentum, while the lower volatility compared with more cyclical sectors reinforces the defensive character of Colgate-Palmolive stock. However, decisions on buying or selling remain highly individual and depend on each investor's risk tolerance and portfolio construction.

Hill's pet nutrition and growth contribution

Beyond toothpaste and home care products, Hill's pet nutrition has become an increasingly important earnings driver. As noted earlier, Hill's sales grew approximately 10% in fiscal 2023 to around $4.5 billion from about $4.1 billion in 2022, representing one of the fastest growing segments within Colgate-Palmolive. The business focuses on science based pet food sold through veterinarians and specialty retailers, with a portfolio that includes therapeutic diets for specific health conditions and everyday premium nutrition options.

Margins in Hill's are attractive due to the premium positioning and strong brand loyalty among pet owners and veterinary professionals. Colgate-Palmolive has invested heavily in production capacity for Hill's, including new facilities or expansions in key markets, to ensure adequate supply and maintain product quality. Capital expenditures related to Hill's operations represent a meaningful portion of the group total, though the high growth and margin structure of the segment supports these investments from a financial perspective.

From a portfolio standpoint, the presence of a growing pet nutrition business within Colgate-Palmolive provides diversification away from more mature oral care markets. It also exposes the company to secular trends in pet ownership and spending, which have shown resilience and growth even through various economic cycles. For some investors, this exposure is part of the appeal of Colgate-Palmolive stock compared with other pure play oral care or household products companies.

Home care, personal care, and emerging markets

Home care and personal care products, including dishwashing liquids, fabric conditioners, and body washes, contribute the balance of Colgate-Palmolive's revenue. In fiscal 2023, these categories together accounted for roughly 30% to 35% of consolidated net sales. While growth rates in these categories vary by region, emerging markets such as India, Southeast Asia, and Africa offer expansion opportunities. The company has been investing in brand building and distribution in these regions, often tailoring products to local preferences and price points.

In many emerging markets, Colgate-Palmolive seeks to strengthen its presence in modern retail channels and e commerce, complementing traditional trade. Digital marketing and partnerships with online platforms form part of the strategy to reach younger consumers and urbanizing populations. Over time, success in these markets could support higher overall growth rates and help sustain the valuation premium associated with Colgate-Palmolive stock, though such expansions also involve competitive and regulatory challenges.

At the same time, the company is mindful of sustainability and social responsibility in these regions, including efforts to reduce plastic usage in packaging, improve water stewardship, and support community programs related to oral health and hygiene. While such initiatives do not directly translate into near term financial metrics, they can influence brand perception and regulatory relationships, which in turn impact long term growth and risk profiles.

Colgate toothpaste as representative product

Against this backdrop, Colgate toothpaste stands out as the representative product most closely associated with Colgate-Palmolive stock in the minds of many consumers and investors. The brand is present in hundreds of millions of households worldwide and has maintained high brand recognition for decades. Innovation in formulations, such as the addition of antibacterial agents, fluoride optimization, and whitening technologies, as well as flavor variants, helps keep the brand relevant and allows the company to segment the market by price and benefit.

Colgate toothpaste revenue is not disclosed as a separate line item in financial statements, but oral care as a whole, which includes Colgate toothpaste, toothbrushes, and mouthwashes, represents more than 40% of sales, as noted earlier. Given this concentration, the performance of Colgate toothpaste is a major factor in overall corporate results. In many markets, the brand commands a price premium over some local competitors, reflecting both perceived quality and strong marketing support, which is important for margin sustainability.

Colgate-Palmolive stock closing context

Looking at the most recent available trading data, Colgate-Palmolive stock closed at around $95 per share on the New York Stock Exchange as of 15 July 2026, leaving it near the upper end of its 52 week trading range between approximately $75 and $100. At this level, the company carried a market capitalization close to $79 billion, anchoring its status as a significant S&P 500 constituent in the consumer staples sector.

Key facts on Colgate-Palmolive stock

• Company: Colgate-Palmolive Company
• ISIN: US1941621039
• Ticker: NYSE: CL
• Trading venue: NYSE
• Price (as of 15 July 2026, 16:00 ET): 95.00 USD
• Market capitalization: 79,000,000,000 USD (as of 15 July 2026)
• Sector / Industry: Consumer Staples / Household and Personal Products
• Index membership: S&P 500